Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
83,722,084
-
Share change
-
-1,777,988
-
Total reported value
-
$1,305,213,656
-
Put/Call ratio
-
7.9%
-
Price per share
-
$15.59
-
Number of holders
-
339
-
Value change
-
-$26,049,213
-
Number of buys
-
146
-
Number of sells
-
166
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2025
As of 31 Dec 2025,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
339 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,722,084 shares.
The largest 10 holders included
Capital Research Global Investors, MORGAN STANLEY, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, GOLDMAN SACHS GROUP INC, D. E. Shaw & Co., Inc., UBS Group AG, FMR LLC, BRANDES INVESTMENT PARTNERS, LP, BlackRock, Inc., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
339
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.